Results 161 to 170 of about 13,334 (226)

LG 30435 is a new bronchodilator agent with multiple sites of action

, 1986
Alessandro Subissi, Marco Criscuoli, Anna Rita Renzetti   +2 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Improving the outcome for children with cancer: Development of targeted new agents

Ca-A Cancer Journal for Clinicians, 2015
Peter C Adamson
exaly  

Bronchodilators/general-anaesthetics/neuromuscular-blocking-agents

Reactions Weekly, 2020
openaire   +1 more source

Epithelial ovarian cancer: Evolution of management in the era of precision medicine

Ca-A Cancer Journal for Clinicians, 2019
Stephanie Lheureux, Marsela Braunstein, Amit M Oza   +2 more
exaly  

STUDIES ON CARBUTEROL (SK&F 40383-A), A NEW SELECTIVE BRONCHODILATOR AGENT

, 1974
J. R. JUN. WARDELL, D.F. Colella, A. Shetzline, Philip J. Fowler   +3 more
openalex   +1 more source

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly  

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle, Taofeek Kunle Owonikoko, Nabil F Saba   +2 more
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

Retrospective study on the use of LABA/LAMA therapy (long acting bronchodilator agent/long acting muscarinic agent) in patients with severe COPD at first diagnosis

, 2019
Francesco Bini, Noemi Grassi, Angelo De Lauretis, Bruno Dino Bodini, Cristina Arosio, Adriano Vaghi   +5 more
openalex   +1 more source

An update on larynx cancer

Ca-A Cancer Journal for Clinicians, 2017
Kristin A Higgins, Nabil F Saba
exaly